# The Potential Cardioprotective Effect of Addition of Atorvastatin in Breast Cancer Patients

> **NCT07668076** · PHASE2 · COMPLETED · sponsor: **Damanhour University** · enrollment: 44 (actual)

## Conditions studied

- Breast Cancer
- Doxorubicin Induced Cardiomyopathy

## Interventions

- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT07668076
- **Lead sponsor:** Damanhour University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-15
- **Primary completion:** 2024-10-20
- **Final completion:** 2024-10-20
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2026-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07668076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07668076, "The Potential Cardioprotective Effect of Addition of Atorvastatin in Breast Cancer Patients". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07668076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*